They were randomly assigned to receive a weekly 2.4-milligram (mg) injection of semaglutide or a placebo (inactive treatment) for 72 weeks
If the infusions will be taking place on a regular basis, the catheter (or port) will be introduced in a way that will allow it to remain in the body as long as needed and accessed at the time of the infusion
The risk varies depending on insulin type, dosing schedule, and individual factors affecting insulin sensitivity
Throughout the course of treating malignant tumors, multiple injections of oncolytic HSV-1 are required, and continuous monitoring of tumor growth is necessary to evaluate whether to administer oncolytic HSV-1 again
GLP-1 agonists handle appetite
Patients and clinicians are advised to watch for severe, ongoing stomach pain, with nausea or vomiting